BB Biotech AG (SWX:BION)

Fund Assets	n/a
Expense Ratio	n/a
Min. Investment	n/a
Turnover	n/a
Dividend (ttm)	2.25
Dividend Yield	4.13%
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Mar 23, 2026

Previous Close	54.50
Volume	28,701
YTD Return	28.50%
1-Year Return	75.04%
52-Week Low	n/a
52-Week High	n/a
Beta (5Y)	0.66
Holdings	n/a
Inception Date	n/a

About BION

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

• Country: Switzerland
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BION

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 23, 2026	2.250 CHF	Mar 25, 2026
Mar 21, 2025	1.800 CHF	Mar 25, 2025
Mar 25, 2024	2.000 CHF	Mar 27, 2024
Mar 27, 2023	2.850 CHF	Mar 29, 2023
Mar 21, 2022	3.850 CHF	Mar 23, 2022
Mar 22, 2021	3.600 CHF	Mar 24, 2021

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 19, 2026

Data Sources Report a data error